Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Eli Lilly dumps Innovent's PD-1 after FDA rebuff, nixing high-profile Chinese cancer drug
Fierce Pharma
Thu, 12/1/22 - 07:03 pm
Tags:
Eli Lilly, Innovent Biologics, Tyvyt, China
Lilly's Covid-19 mAb no longer authorized due to Omicron subvariants, FDA says
Endpoints
Wed, 11/30/22 - 08:04 pm
Tags:
Eli Lilly, FDA, COVID-19, Omicron, bebtelovimab, monoclonal antibodies
Lilly backs $45M investment for mRNA cancer immunotherapy startup
Businesswire
Mon, 11/28/22 - 10:16 am
Tags:
Strand Therapeutics, funding, Eli Lilly, rRNA, cancer
Biggest drug companies halted Twitter ad buys after Lilly insulin spoof
Endpoints
Mon, 11/21/22 - 06:38 pm
Tags:
twitter, social media, pharma ads, Eli Lilly
Eli Lilly to double its manufacturing capacity for Mounjaro as it faces financial headwinds going into 2023 — report
Endpoints
Mon, 11/21/22 - 06:34 pm
Tags:
Eli Lilly, Mounjaro, diabetes, type 2 diabetes, drug manufacturing
Acrivon Nets $100M for Protein Tech That Picks Patients for Targeted Cancer Meds
MedCity News
Sun, 11/20/22 - 12:37 pm
Tags:
Acrivon Therapeutics, Eli Lilly, IPOs, Proteomics, cancer, oncology
Lilly wins FDA approval for second interchangeable insulin biosimilar
Endpoints
Thu, 11/17/22 - 11:27 pm
Tags:
Eli Lilly, FDA, insulin, diabetes, biosimilars
Roche Failure Leaves Industry Reassessing Alzheimer's Space
BioSpace
Wed, 11/16/22 - 10:45 am
Tags:
Roche, Alzheimer's disease, gantenerumab, Biogen, Cassava Sciences, Eli Lilly
Fake Eli Lilly Twitter account falsely claimed insulin 'free'
Indianapolis Star, IN
Fri, 11/11/22 - 10:50 am
Tags:
Eli Lilly, social media, insulin, twitter, Elon Musk
Eli Lilly ordered to pay $177M to rival Teva in migraine patent fight
Fierce Pharma
Thu, 11/10/22 - 10:12 pm
Tags:
Eli Lilly, legal, migraines, Ajovy, patents
Lilly’s new diabetes management platform to integrate Dexcom CGM
Medtech Dive
Wed, 11/9/22 - 10:44 am
Tags:
Eli Lilly, diabetes, DexCom, Medtech, devices, Tempo
Early data hint at benefit for Amgen’s obesity drug
BioPharma Dive
Wed, 11/9/22 - 10:32 am
Tags:
Amgen, obesity, Eli Lilly, Novo Nordisk, AMG 133
Eli Lilly, Boehringer Ingelheim bolster case for Jardiance to treat chronic kidney disease
Fierce Pharma
Sun, 11/6/22 - 01:44 pm
Tags:
Eli Lilly, Boehringer Ingelheim, chronic kideny disease, Jardiance, Farxiga, AstraZeneca
Novo Nordisk’s Ozempic Shortage Spurs Demand for Eli Lilly’s Diabetes Injection Mounjaro
Xtalks
Thu, 11/3/22 - 07:25 pm
Tags:
Eli Lilly, Mounjaro, Novo Nordisk, Ozempic, type 2 diabetes
Lilly sales of new diabetes drug accelerate on rising patient demand
BioPharma Dive
Tue, 11/1/22 - 07:10 pm
Tags:
Eli Lilly, diabetes, Mounjaro, patients
String of gene therapy deals spurs cautious optimism on Wall Street
BioPharma Dive
Tue, 11/1/22 - 07:09 pm
Tags:
gene therapy, M&A, Akouos, AGTC, Taysha Gene Therapies, Astellas, Eli Lilly, Syncona
Lilly powers through final stretch in critical Alzheimer's race
Fierce Biotech
Tue, 11/1/22 - 07:02 pm
Tags:
Eli Lilly, Alzheimer's disease, donanemab, lecanemab, Eisai
Eli Lilly revenue inches up 2%, Pfizer raises full year outlook
Medical Marketing and Media
Tue, 11/1/22 - 11:02 am
Tags:
Eli Lilly, Pfizer, earnings
Systemic lupus erythematosus: major drug trials to watch in 2022 and 2023
Clinical Trials Arena
Mon, 10/31/22 - 10:37 am
Tags:
clinical trials, systemic lupus erythematosus, AbbVie, ABBV-509, Eli Lilly, LY3471851, Merck KGaA, M5049, Swedish Orphan Biovitrum, emapalumab
Eli Lilly commits $92.5M to Purdue University for pharmaceutical manufacturing scholarships
Layfette Journal and Courier, IN
Fri, 10/28/22 - 10:30 am
Tags:
Eli Lilly, philanthropy, drug manufacturing, Purdue University

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.